Literature DB >> 11921133

Thalamic stimulation for midbrain tremor after partial hemangioma resection.

Rajesh Pahwa1, Kelly E Lyons, Lucas Kempf, Steven B Wilkinson, William C Koller.   

Abstract

We describe a patient with disabling medication-resistant midbrain tremor developed after partial hemangioma resection, who responded to deep brain stimulation of the thalamus. Copyright 2002 Movement Disorder Society.

Entities:  

Mesh：

Year:  2002        PMID： 11921133     DOI： 10.1002/mds.10084

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


  5 in total

1.  Deep brain stimulation of the globus pallidus internus or ventralis intermedius nucleus of thalamus for Holmes tremor.

Authors:  Jairo Alberto Espinoza Martinez; Gabriel J Arango; Erich Talamoni Fonoff; Thomas Reithmeier; Oscar Andrés Escobar; Luciano Furlanetti; G Rene Alvarez Berastegui; Fabio Eduardo Fernandes da Silva; William Omar Contreras Lopez
Journal:  Neurosurg Rev       Date:  2015-05-20       Impact factor: 3.042

2.  Deep brain stimulation in uncommon tremor disorders: indications, targets, and programming.

Authors:  Carlo Alberto Artusi; Ashar Farooqi; Alberto Romagnolo; Luca Marsili; Roberta Balestrino; Leonard L Sokol; Lily L Wang; Maurizio Zibetti; Andrew P Duker; George T Mandybur; Leonardo Lopiano; Aristide Merola
Journal:  J Neurol       Date:  2018-03-06       Impact factor: 4.849

3.  Deep brain stimulation for Holmes' tremor related to a thalamic abscess.

Authors:  Selcuk Peker; Ugur Isik; Yasemin Akgun; Memet Ozek
Journal:  Childs Nerv Syst       Date:  2008-06-25       Impact factor: 1.475

4.  Clinical Outcome and Characterization of Local Field Potentials in Holmes Tremor Treated with Pallidal Deep Brain Stimulation.

Authors:  Adolfo Ramirez-Zamora; Brian C Kaszuba; Lucy Gee; Julia Prusik; Fabio Danisi; Damian Shin; Julie G Pilitsis
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2016-06-30

Review 5.  Deep brain stimulation for the treatment of uncommon tremor syndromes.

Authors:  Adolfo Ramirez-Zamora; Michael S Okun
Journal:  Expert Rev Neurother       Date:  2016-06-09       Impact factor: 4.618
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.